Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Homerun Slides: Clinical presentation library Previous | All Articles This Week | Next
This article originally posted 21 January, 2012 and appeared in  Cardiovascular Health, Medication, Medication Slides, Diabetes Clinical Mastery Series Issue 68

Diabetes Mellitus 101 for Medical Professionals, PART 5

DCMS68_HS-Image

In this week's Homerun Slides, we cover such topics as the Potential Mechanisms of reducing CV outcomes with DPP-4 inhibitors, Mechanisms of Incretins, and Insulin Secretagogues: Sulfonylureas and "Glinides"...
Advertisement

To download the complete set of this week's Homerun Slides, just click on this link, Diabetes Mellitus 101 for the Diabetes Professional, Part 5.

Check out all of Diabetes In Control's slide collections at our Clinical Presentations Library. 

 

Related Articles

FDA Approves Two Generics of Clopidogrel (Plavix) Sildenafil Improves Diabetic Cardiomyopathy FDA: Aliskiren in Certain Combinations Can Not Be Used for Diabetic Patients
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 21 January, 2012 and appeared in  Cardiovascular Health, Medication, Medication Slides, Diabetes Clinical Mastery Series Issue 68

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control